Ad is loading...
APRW vs FSEP
APRW vs FSEP Comparison Chart
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
APRW vs. FSEP commentary
Nov 14, 2024
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APRW is a Buy and FSEP is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
FSEP has more net assets: 833M vs. APRW (180M). FSEP has a higher annual dividend yield than APRW: FSEP (14.016) vs APRW (11.157). APRW was incepted earlier than FSEP: APRW (4 years) vs FSEP (4 years).
| APRW | FSEP | APRW / FSEP | |
| Gain YTD | 11.157 | 14.016 | 80% |
| Net Assets | 180M | 833M | 22% |
| Total Expense Ratio | N/A | N/A | - |
| Turnover | N/A | 0.00 | - |
| Yield | 0.00 | 0.00 | - |
| Fund Existence | 4 years | 4 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| APRW | FSEP | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 37% | 2 days ago 49% |
| Stochastic ODDS (%) | 2 days ago 26% | 2 days ago 47% |
| Momentum ODDS (%) | 2 days ago 70% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 57% | 2 days ago 70% |
| TrendWeek ODDS (%) | 2 days ago 53% | 2 days ago 70% |
| TrendMonth ODDS (%) | 2 days ago 51% | 2 days ago 65% |
| Advances ODDS (%) | 7 days ago 49% | 7 days ago 65% |
| Declines ODDS (%) | 3 days ago 38% | 3 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 29% | 2 days ago 52% |
| Aroon ODDS (%) | 2 days ago 50% | 2 days ago 62% |
View a ticker or compare two or three
VS
VS
Ad is loading...
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| USPVX | 30.65 | 0.09 | +0.29% |
| Union Street Partners Value A | |||
| LGMAX | 26.72 | 0.03 | +0.11% |
| Loomis Sayles Global Allocation A | |||
| PEYAX | 38.26 | 0.02 | +0.05% |
| Putnam Large Cap Value A | |||
| MAIMX | 27.38 | -0.03 | -0.11% |
| Victory Integrity Mid-Cap Value A | |||
| ETHSX | 14.37 | -0.05 | -0.35% |
| Eaton Vance Worldwide Health Sci A | |||